Academic leaders, industry experts, government policy makers and healthcare providers from around the nation discuss the latest developments in personalized health care. Topics include: Infrastructure to Enable P4 Medicine, Integrating Proteomic Biomarkers Into Personalized Drug Dosing, and Pharmacogenetics of Statin Therapies.